Patients´preferences for systemic treatment of atopic dermatitis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00025064

Enrollment

500

Registered

2021-04-15

Start date

2021-04-16

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

L20

Interventions

Group 1: Conjoint analysis is used to examine patients´preferences for systemic treatment of atopic dermatitis

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: • Presence of a medically diagnosed atopic dermatitis • Age = 18 years • Consent to participate in the study

Exclusion criteria

Exclusion criteria: Minority, lack of consent to participate in the study

Design outcomes

Primary

Measure	Time frame
Conjoint analysis is used to examine which properties of the established and new therapies are particularly important from the perspective of patients with neurodermatitis.	—

Secondary

Measure	Time frame
Secondary study objectives are to determine the influence of patient characteristics on these preferences.	—

Countries

Germany

Contacts

Public ContactMarthe-Lisa Schaarschmidt

Klinik für Dermatologie, Venerologie und Allergologie, Universitätsmedizin Mannheim

marthe-lisa.schaarschmidt@umm.de00496213832280

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026